Figure 1: Summary of the preclinical and non clinical development of biopharmaceuticals. Abbreviations used: NCE, New Chemical Entities; GLP, Good Laboratory Practice; MTD, Maximum Tolerated Dose; PK, Pharmacokinetics; PD, Pharmacodynamics; TCR, Tissue Cross Reactivity; SP, Safety Pharmacology; Seg, Segment; ePPND, Enhanced Pre- and Post-Natal Development.

Goto home»